Pricing Log in Create free account
Saturday 17 October 2026 Export MCK’s income statement to Excel — free account

McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.

1,006.92 8.28 +0.83%
Market cap
$116.4B
P/E
26.8×
Fwd P/E
18.3×
Dividend yield
0.34%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

McKesson Corporation 10-K filed May 8, 2026

Fiscal year 2026 · Period ended Mar 31, 2026 · Filed · accepted 5:35 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1, Business, against the 10-K filed May 9, 2025: 11 added · 7 removed · 46 modified; 3 with only figures updated; 9 moved without change

  1. Modified · INDEX TO BUSINESS

    Section | Page General | 3 Business Segments | 4 U.S. North American Pharmaceutical | 4 Prescription Technology SolutionsOncology & Multispecialty | 7 Medical-Surgical Prescription Technology Solutions | 7 International 8 Medical-Surgical Solutions | 78 Investments, Restructuring, Business Combinations, and Divestitures | 8 Competition | 8 Patents, Trademarks, Copyrights, and Licenses | 89 Human Capital | 9 Government Regulation | 910 Other Information about the Business | 1213 Forward-Looking Statements | 1214

63 more changes in this Item, word by word, in Powerpack.

Powerpack